
The National Research Council (NRC), Environment and Climate Change Canada (ECCC), Health Canada (HC) and Public Services and Procurement Canada (PSPC) are actively seeking innovative, cost-effective, safe, and scalable solutions that lead to the destruction of per- and polyfluoroalkyl substances (PFAS) compounds across various contaminated solid or aqueous media such as water, soil, biosolids as well as spent filtration media such as granular activated carbon and resins.
Challenge sponsors:
NRC, ECCC, PSPC and HC
Funding mechanism:
Grant
Opening date:
October 9, 2024
Closing date:
November 20, 2024, 14:00 Eastern Time
Here are a few things you need to know before you get started on your application to this challenge:
- This challenge is only open to receive proposals for Phase 1 (Proof of Feasibility) of our Challenge Stream. Proposed solutions that fall within technology readiness levels (TRL) 1-4 can be submitted to this challenge.
- We recently made changes to the Challenge Stream, we have outlined the new parameters here.
- Read through the official Grant Instructions and Procedures document.
Challenge
Problem statement
Per- and polyfluoroalkyl substances (PFAS) are a widely used group of chemicals that are known for their persistence in the environment. Overtime, they either remain unchanged or transform to persistent substances, leading to exposure and accumulation. These substances are an important component in aqueous film forming (AFFF) foams for fire suppression and are also found in a multitude of commercial and consumer products, including (but not limited to) cosmetics, non-stick cookware, and textiles. Due to their widespread use and their persistence, PFAS are found nearly everywhere in the environment, including in air, surface and groundwater, oceans, soils, wastewater, landfill leachate, and biosolids. Certain PFAS have been also widely detected in biomonitoring studies of humans and animals. Research has shown that well-studied PFAS can affect multiple organs including, liver, kidney, thyroid, immune, nervous and reproduction systems.
The persistence and mobility of PFAS make their contamination of surface water, groundwater, drinking water, sediment and soil a pressing concern.
In May 2023, Environment and Climate Change Canada and Health Canada published a Draft State of PFAS Report for public comment. An Updated Draft State of PFAS Report and Revised Risk Management Scope (Reference 1) was published in July 2024, also for a 60-day comment period. The updated draft report proposes that the class of PFAS, excluding fluoropolymers as defined in the Report, is proposed to meet the criteria under paragraphs 64(a) and (c) of the Canadian Environmental Protection Act, 1999 (CEPA), as these substances are entering or may enter the environment in a quantity or concentration or under conditions that have or may have immediate or long-term harmful effects on the environment or its biological diversity, and that constitute or may constitute a danger in Canada to human life or health or harm the environment.
The commercial market for PFAS detection, removal, and destruction technologies is rapidly evolving due to growing awareness of PFAS contamination and increasing regulation. The challenge lies in the difficulty and high cost of destroying PFAS even when they are successfully removed from the environment (e.g. PFAS in spent filtration media as a result of remediating contaminated sites). Without intervention and appropriate management, the presence of PFAS in the environment will continue to rise, and will become increasingly challenging to mitigate.
The goal of this ISC challenge is to develop new technologies and approaches capable of destroying at least 99 percent of PFAS in various waste streams through defluorination of the perfluoroalkyl chain, without creating harmful by-products. In the case where derivatives are created, they must be controlled and destroyed before any release into the environment.
Desired outcomes and considerations
Essential (mandatory) outcomes
The proposed solution must:
- Demonstrate efficacy for the destruction of at least 99 percent of PFAS in different media such as contaminated ground or wastewater, soil, biomass, biosolids, and spent contaminated filtration media.
- Destroy (De-fluorinate and mineralize highly concentrated) both long-chain (≥ C8) and short-chain PFAS (< C8) compounds, as represented by the individual PFAS identified in Government of Canada (GoC)-recommended analytical methods, ensuring no formation of toxic derivatives (as defined under Section 64 in the Canadian Environmental Protection Act, 1999) and complete breakdown to non-toxic by-products
- Destroy PFAS in any contaminated filtration media utilized in the treatment process which may also contain co-contaminants.
- Demonstrate how the proposed solution is scalable and more cost-effective than existing destruction methods, supported by a cost analysis to confirm its economic viability for large-scale implementation.
- Have no negative impact on human health and be compliant with all applicable Canadian environmental regulations, criteria and standards for waste treatment and disposal.
- Provide a risk assessment and mitigation strategy for any potential hazards associated with the technology/process adoption.
- Define individual processes used in the design and demonstrate degradation efficiency, treatment time, and energy consumption.
- Validate destruction and defluorination with analytical data and evidence from an independent accredited laboratory on
- ex-situ contaminated samples (Phase 1)
- in-situ contaminated pilot site (Phase 2)
Additional outcomes
The proposed solution should:
- Provide a fluorine mass balance study and an analysis of the destruction pathway, experiment parameters, chemistry and by-products formation (in particular toxic by-products), formed during the application of the treatment approaches.
- Provide a Life Cycle Inventory that catalogues energy, materials, and waste at each stage of the process.
- Propose methods that can be integrated with existing waste management and treatment infrastructure.
- Prioritize the use of Canadian-sourced materials and expertise where possible.
- Be easily deployable in a reasonable timeframe.
- Demonstrate adaptability to various environmental conditions and contamination levels, including the removal and destruction selectivity and potential interference from other chemicals or contaminants during the process.
Notes:
- The class of PFAS defined for this challenge is according to the OECD (2021) which is any fluorinated substances that contain at least one fully fluorinated methyl or methylene carbon atom (without any H/Cl/Br/I atom attached to it), i.e. with a few noted exceptions, any chemical with at least a perfluorinated methyl group (–CF3) or a perfluorinated methylene group (–CF2–).
- Long-chain (≥ C8) and short-chain PFAS (< C8) PFAS are defined in Reference 1.
- The Guidelines for Canadian Drinking Water Quality (Aug 2024, Reference 2) stipulates that the sum of 25 specified PFAS should not exceed 30 ng/L.
- The US EPA Method 1633 specifies 40 PFAS compounds (Reference 3) that should be considered for the destruction solution. For the purpose of this challenge, the solution must destroy at a minimum the following PFAS:
- PFOS (perfluorooctane sulfonate, its salts and precursors)
- PFOA (perfluorooctanoic acid, which has the molecular formula C7F15CO2H, its salts and precursors)
- LC-PFCAs (long-chain perfluorocarboxylic acids that have the molecular formula CnF2n+1CO2H in which 8 ≤ n ≤ 20, their salts and their precursors)
- HFPO-DA (hexafluoropropylene oxide dimer acid) also known as GenX
- PFHxA (Perfluorohexanoic Acid)
- PFHxS (Perfluorohexanesulfonic acid)
- 6:2 FTS (Fluorotelomer sulfonic acid, 6:2)
- PFHpA (Perfluoroheptanoic acid)
- PFNA (Perfluorononanoic acid)
- PFPeA (Perfluoropentanoic acid)
- PFBS (Perfluorobutanesulfonic acid)
- For Phase 1 testing and validation, contaminated samples will be provided by the challenge sponsors.
- For Phase 2 validation, access to a contaminated site will be provided by the challenge sponsors for a pilot demonstration. Security clearance to the site may be required.
- Any PFAS-contaminated samples or used filtration media must be disposed of or treated in accordance with all applicable Canadian environmental regulations, criteria and standards for waste treatment and disposal.
Background and context
PFAS investigation/assessment, removal and destruction is estimated to be the fastest growing environmental market globally, with numerous contaminated sites requiring remediation efforts. There are thousands of known PFAS-contaminated sites across North America (Reference 4), including industrial facilities, airports, military bases, and municipal landfills. There are known confirmed or suspected PFAS contaminated sites in Canada's military bases and airports (Reference 5). The market value for PFAS removal and destruction services is significant, with estimates reaching several billion dollars by 2030 and the PFAS waste management market valued at US$2.9B in 2031 (Reference 6).
This challenge fits within Canada's commitment (Reference 7) to protect the health and safety of Canadians and the environment from the harmful effects of PFAS contamination.
Maximum contract value and travel
Multiple awards could result from this Challenge.
Phase 1: The objective of Phase 1 is for selected applicants to conduct a bench-scale test on their proposed solutions. Applicants must deliver proof of feasibility after conducting ex-situ testing on provided PFAS-contaminated water or soil or biosolids samples, comparing the concentration of PFAS before and after treatment. In this phase, the risks and advantages of the proposed technology or process adoption should be identified.
- The maximum funding available for any Phase 1 grant resulting from this Challenge is: $200,000 CAD
- The maximum duration for any Phase 1 project funded by a grant resulting from this Challenge is up to 6 months
- Estimated number of Phase 1 grants: 3
Phase 2: The objective of Phase 2 is to conduct R&D on the proposed solution and develop a pilot demonstration to conduct in-situ testing prior to and after destruction at a PFAS-contaminated test site.
- The maximum funding available for any Phase 2 grant resulting from this Challenge is: $1,500,000 CAD
- The maximum duration for any Phase 2 project funded by a grant resulting from this Challenge is up to 18 months
- Note: Only eligible businesses that have completed Phase 1 could be considered for Phase 2.
- Estimated number of Phase 2 grants: 1
Note: Selected companies are eligible to receive one grant per phase per challenge.
This disclosure is made in good faith and does not commit Canada to award any grant for the total approximate funding. Final decisions on the number of Phase 1 and Phase 2 awards will be made by Canada on the basis of factors such as evaluation results, departmental priorities and availability of funds. Canada reserves the right to make partial awards and to negotiate project scope changes.
Travel
No travel is anticipated during Phase 1.
Some travel is expected by the successful applicant during Phase 2 to and from the pilot test site.
Kick-off meeting
All communication will take place by telephone or videoconference.
Progress review meeting(s)
Any progress review meetings will be conducted by telephone or videoconference.
Final review meeting
All communication will take place by telephone or videoconference.
Eligibility
Solution proposals can only be submitted by a small business that meets all of the following criteria:
- for profit
- incorporated in Canada (federally or provincially)
- 499 or fewer full-time equivalent (FTE) employeesFootnote **
- research and development activities that take place in Canada
- 50% or more of its annual wages, salaries and fees are currently paid to employees and contractors who spend the majority of their time working in CanadaFootnote **
- 50% or more of its FTE employees have Canada as their ordinary place of workFootnote **
- 50% or more of its senior executives (Vice President and above) have Canada as their principal residenceFootnote **
Evaluation criteria
Phase 1
The Applicant (offeror) must complete the Challenge Stream Submission Form with a degree of information sufficient to enable Canada's assessment of the proposal against the criteria and the Evaluation Schema. The information must demonstrate how the proposal meets the criterion. The Applicant (offeror) may not add information to their submission at a later time.
Part 1: Phase 1 - Mandatory Criteria
Proposals must meet all Mandatory Criteria identified by achieving a "Pass" in order to proceed to Part 2. Proposals that do not meet all Mandatory Criteria will be deemed non-responsive and given no further consideration.
Mandatory Criteria
(Applicant's proposal must address)
Question 1 a: Scope
Describe the proposed innovation and demonstrate how it responds to the challenge. Include in your description the scientific and technological basis upon which the solution is proposed and clearly demonstrate how the solution meets all of the Essential Outcomes in the Desired Outcomes section in the Challenge Notice.
Question 1 a: Evaluation Schema (Mandatory – Pass/Fail)
Pass
The proposed innovation is within the scope for the challenge, and clearly addresses all Essential Outcomes identified in the Challenge.
Fail
The proposed solution is articulated as out of scope for the challenge.
or
The proposal does not clearly demonstrate how the proposed solution addresses all Essential Outcomes identified in the challenge.
or
The proposed solution is poorly described and does not permit concrete analysis.
or
There is little to no scientific and/or technological evidence that the proposed solution is likely to meet all Essential Outcomes.
Question 2: Current Technology Readiness Level (TRL)
- Indicate the current TRL of the proposed solution. (Drop Down Menu of the Challenge Stream Submission Form)
- Describe the research and development activities that have taken place to bring the proposed solution to the stated TRL.
This section should include:
- A description of the method of research
- The solution objectives and an analysis of the results proving the feasibility of the solution
- Data proving the solution's feasibility
- Evidence to demonstrate the highest level of validation conducted (e.g. activities such as paper studies, analytic studies, components that are not yet integrated or representative, integration of "ad hoc" hardware in the laboratory, laboratory testing, simulated environment, field testing, debugging, etc.)
- The type of environment(s) in which this was done and by whom, including title
Question 2: Evaluation Schema (Mandatory – Pass/Fail)
Pass:
The Applicant (offeror) has demonstrated that the proposed solution is currently between TRL 1 to 4 (inclusive), and provided justification by explaining the research and development (R&D) that has taken place to bring the solution to the stated TRL.
Fail:
The Applicant (offeror) has not provided sufficient evidence to demonstrate that the current TRL is between 1 to 4 (inclusive) including:
- There is insufficient/no evidence provided for TRL judgment.
- The solution involves the development of basic or fundamental research.
- The solution is demonstrated at TRL 5 or higher.
- Insufficient/unclear/no justification explaining the R&D that took place to bring the solution to the stated TRL.
- The explanation simply paraphrases the description of a given TRL level.
Question 3a: Innovation
Demonstrate how the proposed solution meets one or more of the ISC definitions of innovation below:
- An inventionFootnote *, new technology or new process that is not currently available in the marketplace.
- Significant modifications to the application of existing technologies/components/processes that are applied in a setting or condition for which current applications are not possible or feasible.
- An improvement in functionality, cost or performance over an existing technology/process that is considered state-of-the-art or the current industry best practice.
Question 3a: Evaluation Schema (Mandatory – Pass/Fail)
Pass:
The proposed solution meets one or more of the ISC definitions of innovation.
Fail:
- The proposed solution does not meet any of the ISC definitions of innovation
or - The proposed solution is an incremental improvement, "good engineering", or a technology that would go ahead in the normal course of product development (i.e. the next version or release).
Question 3b: Advance on State of the Art
Describe in detail the competitive advantages and level of advancement over existing technologies. Where appropriate, name existing technologies as well as potential substitutes or competitors.
To demonstrate this, the proposal must include the following information:
- Improvements (minor or major) over existing technologies or substitutes. Use direct comparison.
- How the proposed innovation will create competitive advantages in existing market niches or market spaces.
Question 3b: Evaluation Schema (Mandatory Criteria – Pass/Fail + Points)
0 points/Fail:
- The Applicant (offeror) has not demonstrated that the proposed solution advances the state-of-the-art over existing technologies, including available competing solutions; or
- The proposed solution improves minimally upon the current state of the art, though not sufficiently enough to create competitive advantages in existing market niches; or
- The stated advancements are described in general terms but are not substantiated with specific, measurable evidence.
5 points/Pass:
- The Applicant (offeror) has demonstrated that the proposed solution offers one or two minor improvements to existing technologies, including available competing solutions that have potential to create competitive advantages in existing market niches.
12 points/Pass:
- The Applicant (offeror) has demonstrated that the proposed solution offers three or more minor improvements to existing technologies, including available competing solutions, that together are likely to create competitive advantages in existing market niches; or
- The Applicant (offeror) has demonstrated that the proposed solution offers one significant improvement to existing technologies that is likely to create competitive advantages in existing market niches.
20 points/Pass:
- The Applicant (offeror) has demonstrated that the proposed solution offers two or more significant improvements to existing technologies, including available competing solutions that are likely to create competitive advantages in existing market niches and could define new market spaces; or
- The Applicant (offeror) has demonstrated that the proposed solution can be considered a new benchmark of state of the art that is clearly ahead of competitors and that is likely to define new market spaces.
Part 2: Phase 1 - Point-Rated Criteria
Proposals must meet the overall minimum pass mark of 65 of 130 possible total points (50%) to be deemed responsive. Proposals that do not achieve the minimum pass mark will be declared non-responsive and given no further consideration.
Point-Rated Criteria
(Applicant's proposal to address)
Question 1b: Scope
Demonstrate the scientific and technological basis of how the proposed solution addresses the Additional Outcomes (if identified) in the Desired Outcomes section in the Challenge Notice. If no Additional Outcomes are identified in the Challenge Notice, text entered in this section will not be considered.
If no Additional Outcomes are identified in the Challenge Notice, Applicants (offerors) will receive 10 points.
Question 1b: Evaluation Schema (Point-Rated)
- Insufficient or no information provided to demonstrate that the solution will address any of the Additional Outcomes. 0 points
- Information provided demonstrates that the solution will address some (<50%) of the Additional Outcomes. 3 points
- Information provided demonstrates that the solution will address most (50% or more) of the Additional Outcomes. 6 points
- Information provided demonstrates that the solution will address all (100%) of the Additional Outcomes. 10 points
Question 4: Phase 1 Science and Technology (S&T) Risks
Identify potential scientific and/or technological risks to the development of the proof of feasibility and describe how they will be mitigated in Phase 1.
Question 4: Evaluation Schema (Point-Rated)
- Information is insufficient or no information provided to demonstrate that the Applicant (offeror) has identified potential risks and described associated mitigation strategies or information provided contains significant gaps in risks and/or associated mitigation strategies. 0 points
- Information provided demonstrates that the Applicant (offeror) has identified potential risks and described associated mitigation strategies but there are minor gaps in risks and/or associated mitigation strategies. 5 points
- Information provided demonstrates that the Applicant (offeror) has identified the potential risks and described associated mitigation strategies. 10 points
Question 5: Phase 1 Project Risks
Identify potential project risks to the development of the proof of feasibility and describe how they will be mitigated in Phase 1.
Applicants (offerors) should address the following risks:
- Human Resources
- Financial
- Project Management
- Intellectual Property
- Supply chain issues
Note: S&T risks should not be included in this section. Question 4 addresses S&T risks.
Question 5: Evaluation Schema (Point-Rated)
- Information is insufficient or no information provided to demonstrate that the Applicant (offeror) has identified potential risks and described associated mitigation strategies or information provided contains significant gaps in risks and/or associated mitigation strategies. 0 points
- Information provided demonstrates that the Applicant (offeror) has identified potential risks and described associated mitigation strategies but there are minor gaps in risks and/or associated mitigation strategies. 5 points
- Information provided demonstrates that the Applicant (offeror) has identified the potential risks and described associated mitigation strategies. 10 points
Question 6: Phase 1 Project Plan
Demonstrate a Proof of feasibility Phase 1 project plan by completing the table in the Proposal Submission Form.
- Indicate if any milestones and activities will be completed concurrently
- Indicate the estimated exit TRL at the completion of Phase 1. (Drop Down Menu of the Challenge Stream Submission Form)
Question 6: Evaluation Schema (Point-Rated)
- Insufficient or no information provided to demonstrate a feasible project plan for Phase 1 and/or the project plan exceeds the maximum duration indicated in the Challenge Notice. 0 points
- Information is feasible for the Phase 1 project plan but not clearly demonstrated and/or includes gaps. 10 points
- Information provided demonstrates a feasible project plan for Phase 1. 20 points
Question 7: Phase 1 Implementation Team
Demonstrate how the project implementation team has the required management and technological skill sets and experience to deliver the project plan for Phase 1 by completing the table. A member of the implementation team can have more than one role.
Question 7: Evaluation Schema (Point-Rated)
- Insufficient or no information provided to demonstrate that the project team has the required management and technological skill sets and experience to deliver the Phase 1 project plan. 0 points
- Information provided demonstrates that there are minor gaps in required management and/or technological skill sets and/or experience to deliver the Phase 1 project plan.10 points
- Information provided demonstrates that the project team has the required management and technological skill sets and experience to deliver the Phase 1 project plan. 20 points
Question 8: Inclusivity
A key objective of the Innovative Solutions Canada program is to increase the participation of under-represented groups in the research and development of the proposed solution.
Applicants (offerors) should describe the policies, strategies, and/or procedures (e.g. recruitment strategy, internships, co-op placements, or other initiatives) that they currently have in place or would put in place to support the R&D effort in Phase 1 including an overview of the group(s); and which specific under-represented groups (women, youth, persons with disabilities, Indigenous people, visible minorities, 2SLGBTQI+ community, etc.).
Note: Do not provide any personal information of individuals employed by your company or that of your subcontractors in the response.
Question 8: Evaluation Schema (Point-Rated)
- No description and/or concrete examples of actions provided that are in place or would be taken to encourage greater participation of under-represented groups. 0 points
- A description and concrete examples of actions to encourage greater participation of under-represented groups provided. 10 points
- If the Applicant (offeror) is registered on the Indigenous Business Directory, Modern Treaty or Comprehensive Land Claim Agreement (CLCA) business list/directory, please provide this information as part of this criterion. A registered Indigenous Businesses will receive the maximum score for Question 8: Inclusivity. 20 points
Question 9: Phase 1 Financial Controls, Tracking and Oversight
Describe the financial controls, tracking and oversight that will be used to manage the funds throughout Phase 1. Applicants (offerors) should indicate if an individual or firm will be managing the funds and provide their credentials and/or relevant experience.
A good financial control in R&D refers to effective management and oversight of financial resources allocated to R&D activities, with the goal of maximising the return on investment and ensuring funds are used efficiently and effectively.
For example, this section could include (but not limited to):
- Establishing clear budgets and financial plan
- Regular monitoring
- Developing systems for tracking and recording costs (salaries, equipment and supplies, overhead expenses, etc.)
- Providing accurate and timely financial reports (including actual and projected costs) to stakeholders such as management, funders or researchers
- Ensuring compliance with relevant financial regulations, policies and procedures
Question 9: Evaluation Schema (Point-Rated)
- Insufficient or no information provided to demonstrate the Applicant's ability to manage funds in Phase 1. 0 points
- Information provided is vague and/or contains gaps. The Applicant (offeror) has some financial controls, tracking and/or oversight in place to manage the funds in Phase 1. 5 points
- Information provided demonstrates that the Applicant (offeror) has financial controls, tracking and oversight to manage funds in Phase 1. 10 points
Question 10: Phase 2 Overview
Demonstrate an overview for the prototype development plan if selected to participate in Phase 2.
Responses should include:
- key tasks
- estimated cost for materials
- human resources
- project risks and mitigation strategies
Note: A more detailed project plan may be requested if selected for consideration to participate in Phase 2.
Question 10: Evaluation Schema (Point-Rated)
- Insufficient or no information provided to demonstrate that the Applicant (offeror) has contemplated an overview for the Phase 2 prototype development. 0 points
- Information provided demonstrates an overview for Phase 2 prototype development, however it is vague and/or contains gaps. 5 points
- Information provided demonstrates that the Applicant (offeror) has a defined overview for the Phase 2 prototype development. 10 points
Questions and answers
Would riskier, but environmentally friendly, solutions which generate no toxic by-products be considered?
ISC's Destruction of PFAS compounds in contaminated media challenge is looking for highly effective solutions, targeting 99% destruction of per- and polyfluoroalkyl substances (PFAS), along with any associated by-products and generated contaminated filtration media utilized during pre-treatment and remediation of samples.
Proposed technologies must demonstrate scalability, compliance with environmental safety standards, and a minimal ecological footprint. Therefore, the challenge is open to innovative approaches that can deliver these outcomes reliably, while reducing any negative environmental impact
The chemical analysis of PFAS samples requires unique equipment that would likely only be used for PFAS R&D. We are wondering if the purchase of analytical equipment tailored to PFAS would be funded by this program, and in what percentage? If not covered, please provide details about the depreciation costs that are covered (please give an example calculation).
Under the ISC program, we typically do not cover the full cost of equipment purchases. However, depreciation costs can be funded as part of capital costs. These include equipment, testing tools, and instruments with residual values, as determined by Generally Accepted Accounting Principles (GAAP), at the end of the funding period. Eligible expenses under ISC include the prorated utilization/depreciation costs of capital items (fixed assets) specifically required for the delivery of the project. These costs should be listed under “Operating Expenses,” accompanied by the necessary justification.
PFAS destruction methods will produce a waste stream that contains F in various forms (such as F-). Would a technology that deals with the clean-up downstream of PFAS destruction (to deal with their byproducts) would be eligible for this call?
The challenge expects a complete system for 99% destruction of PFAS. A technology that focuses solely on cleaning up downstream by-products (such as F-) from PFAS destruction will not be eligible as a stand-alone solution. However, the lead SME can engage another firm as a subcontractor (up to 33% of the total cost) to provide the required components to destroy at least 99% of PFAS in the sample as well as any harmful by-products or derivatives. Any derivatives must be controlled and destroyed within the proposed solution before being released into the environment.
As outlined in the challenge, the proposed solution must include mechanisms for complete PFAS destruction, including dealing with all by-products, as demonstrated in both ex-situ and in-situ settings, and supported by independent laboratory validation.
Please provide the project timeline (evaluation, due diligence, release of funding for Phase 1 and Phase 2)?
We anticipate that Phase 1 work will begin in March 2025, with funding disbursed upon execution of the grant agreement. Phase 1 will last for six months, after which firms that successfully complete their projects will be eligible for Phase 2. We expect Phase 2 to begin in late 2025 or early 2026.
What can or should be assumed for the anticipated concentration(s) in challenge sample and the general (media/matrix) chemical and physical properties?
Spiked samples will be prepared by an accredited laboratory and shipped to successful applicants. The concentration and form of the samples—whether in solution or solid phase—will depend on the specific requirements of the destruction technology being evaluated. Upon selection, applicants will receive detailed information on the matrix identity and sample concentration.
Approximately when would the challenge sample be delivered, and what mass will be conveyed?
The timing of sample delivery will be coordinated with applicants after the selection process is complete. At that point, applicants will also receive specific details about the mass and concentration of the sample provided for testing.
Is the proponent allowed to modify the challenge sample matrix and/or concentrate and/or phase transfer PFAS before destruction?
Yes, proponents are allowed to modify the challenge sample matrix, concentration, and/or phase transfer of PFAS prior to initiating the destruction process. However, it is crucial that all contaminants are effectively destroyed in accordance with the specified challenge outcomes.
What limitations, if any, are there on subcontracting effort inside or outside of Canada?
According to the Innovative Solutions Canada (ISC) Phase 1 rules, applicants are permitted to subcontract up to one-third of the Phase 1 work. This subcontracting allowance applies regardless of whether the subcontracted effort is conducted within or outside of Canada.
What limitations, if any, are there on using grant funds to purchase equipment, including but not limited to a specialised reactor vessel from the United States?
The Innovative Solutions Canada (ISC) program does not allow for the direct purchase of equipment using grant funds. However, it does allow for the cost of utilization or depreciation of capital items (fixed assets), such as equipment, testing tools, and instruments, if they are specifically required for the delivery of the eligible project.
Could a method for increased removal of PFAS from water be considered for this challenge, or is it necessary that it be a destruction technology?
The proposed solution must be a PFAS destruction technology, in line with the objectives of the challenge. This challenge focuses specifically on contaminant removal through destruction methods, not removal or filtration technologies.
In point 8 of the essential/ mandatory outcomes, it states that the solution must “validate destruction and defluorination with analytical data and evidence from an independent, accredited laboratory on a) ex-situ contaminated samples (Phase 1).” Could you clarify whether these samples will be provided in advance, or will we have access to information about their composition to facilitate our validation?
Ex-situ contaminated samples for Phase 1 will be provided after the selection process is complete. At that time, the sample delivery timing, along with the specific mass, concentration, and composition of the sample, will be discussed with applicants.
For Phase 1, one of the important aspects of the project will be to demonstrate this efficiency through analysis of the feed and end products. We would like to know if these analyses can be performed by a government agency. This would not only reduce the project cost on our side, but it would also ensure an independent evaluation of the performance of the solution.
Spiked samples will be prepared by an accredited lab and shipped to the applicants. Depending on the destruction technology, samples will be provided in either solution or solid phase. The matrix identity and sample concentration will be communicated after applicant selection. NRC will supply the feed samples along with their characterization. Additionally, NRC will offer applicants options for selecting accredited labs to perform the analysis of the treated samples following PFAS destruction, ensuring the required characterization is achieved.
For more information, questions regarding this specific challenge should be addressed to solutions@ised-isde.gc.ca.
All enquiries must be submitted in writing no later than ten calendar days before the Challenge Notice closing date. Enquiries received after that time may not be answered.
A glossary is also available.